Conversion From Calcineurin Inhibitors to Belatacept in HLA-sensitized Kidney Transplant Recipients With Low-level Donor-specific Antibodies. Ulloa, Camilo E.; Anglicheau, Dany; Snanoudj, Renaud; Scemla, Anne; Martinez, Frank; Timsit, Marc-Olivier; Legendre, Christophe; Sberro-Soussan, Rebecca. Transplantation. 2019; 103: p.2150-2156. doi:10.1097/TP.0000000000002592Article
Épidémiologie clinique